---
title: "Apeloa Pharmaceutical Subsidiary Gets China Approval for Antibiotics"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/268186949.md"
description: "Apeloa Pharmaceutical Subsidiary Gets China Approval for Antibiotics"
datetime: "2025-12-02T05:15:44.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/268186949.md)
  - [en](https://longbridge.com/en/news/268186949.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/268186949.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/268186949.md) | [繁體中文](https://longbridge.com/zh-HK/news/268186949.md)


# Apeloa Pharmaceutical Subsidiary Gets China Approval for Antibiotics



### Related Stocks

- [APELOA (000739.CN)](https://longbridge.com/en/quote/000739.CN.md)

## Related News & Research

- [Apeloa Pharmaceutical Obtains Drug Registration for Levocarnitine Injection](https://longbridge.com/en/news/263996571.md)
- [Apeloa Pharmaceutical Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2025](https://longbridge.com/en/news/262086974.md)
- [Forest Cabin Schedules Board Meeting to Approve 2025 Results and Consider Dividend](https://longbridge.com/en/news/278848991.md)
- [Measles cases in South Carolina rise by 2 to 993, state health department says](https://longbridge.com/en/news/278595427.md)
- [Know a rising star in pharma marketing? Nominate them here](https://longbridge.com/en/news/278461777.md)